Green Horizon Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth %
- Net Worth 0.55%
- Total Assets 134.31%
About Green Horizon Biotechnology
Green Horizon Biotechnology Private Limited (GHBPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 June 2017 (Seven years and eight months 6 days old ). Its registered office is in Murshidabad, West Bengal, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hemanto Pramanik, Mistu Singha, and Amarjit Basu serve as directors at the Company.
Company Details
-
Location
Murshidabad, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999WB2017PTC221352
-
Company No.
221352
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Jun 2017
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Green Horizon Biotechnology?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemanto Pramanik
|
Director | 05-Jul-2019 | Current |
|
Mistu Singha
|
Director | 05-Jul-2019 | Current |
|
Amarjit Basu
|
Director | 05-Jun-2017 | Current |
Financial Performance of Green Horizon Biotechnology.
Green Horizon Biotechnology Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 0.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Green Horizon Biotechnology?
In 2019, Green Horizon Biotechnology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Alpana Bose Memorial FoundationAmarjit Basu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Green Horizon Biotechnology?
Unlock and access historical data on people associated with Green Horizon Biotechnology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Green Horizon Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Green Horizon Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
